Freddy T. Nguyen, MD, PhD – 2025 MIT Health Science Forum: Treatment Effectiveness, New Biology Using AI - Enabled Nanosensor Technology (MIT Industrial Liaison Program - Startup Exchange)

Freddy T. Nguyen, MD, PhD

Research Fellow @ Massachusetts Institute of Technology

CEO, Co-Founder @ Nine Diagnostics

Physician-scientist developing biophotonics and nano technologies for functional precision medicine to provide the right treatment to the right patient at the right time.

2025 MIT Health Science Forum: Treatment Effectiveness, New Biology Using AI – Enabled Nanosensor Technology (MIT Industrial Liaison Program – Startup Exchange)

MIT Industrial Liaison Program Health Science Forum 2025

MIT Startup Exchange Lightning Talks

Determining Treatment Effectiveness, Discovering New Biology Using AI – Enabled Nanosensor Technology

Freddy Nguyen CEO & Co-Founder, Nine Diagnostics

2025 MIT Health Science Forum here: https://ilp.mit.edu/Health25

Cancer, Innovation, Nanotechnology, Photonics, Precision

May 8, 2025

Related News and Publications

O blood usage trends in the pediatric population 2015–2019 A multi-institutional analysis

March 28, 2025

Nine Diagnostics Joins American Cancer Society’s BrightEdge Entrepreneurs Program

February 12, 2025

Nine Diagnostics Selected for Merck Digital Sciences Studio Cohort 3

November 14, 2024

©

2025

Freddy Nguyen

Massachusetts Institute of Technology
77 Massachusetts Avenue
Cambridge, MA 02139